Tue05212019

Robins Global News & Noticias



  • Shipping Advice
    Shipping Advice
  • Featured Guest Post
    Featured Guest Post
  • Featured Guest Post
    Featured Guest Post
  • Featured Guest Post
    Featured Guest Post
  • Trump Pence News
    Trump Pence News
  • Weather Alerts
    Weather Alerts

RobinsPost News Network

+ Larger Font | + Smaller Font

Globe NewsWire News Distribution Service

Press Release: Global Blood Therapeutics Announces Proposed Public Offering of Common Stock


SOUTH SAN FRANCISCO, Calif., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (Nasdaq: GBT), a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities, today announced an agreement to sell $150.0 million in shares of its common stock in a registered underwritten public offering.  In addition, GBT has granted the underwriter a 30-day option to purchase up to $22.5 million in shares of its common stock.
Cantor Fitzgerald & Co. is acting as the sole book-running manager for the offering.GBT intends to use the net proceeds from the offering and its existing capital resources to fund its clinical development of voxelotor for the treatment of sickle cell disease, including its ongoing clinical studies, as well as preparation for the potential commercial launch of voxelotor, if approved by the U.S. Food and Drug Administration, future clinical trials of voxelotor and other product candidates that GBT may elect to pursue, including inclacumab, its other research and development activities, and for working capital and general corporate purposes. GBT may also use a portion of the net proceeds to in-license, acquire or invest in new business, technology or assets, although it has no material agreements, commitments or understandings in place.An automatic shelf registration statement relating to the shares of common stock offered in the public offering described above was filed with the Securities and Exchange Commission (SEC) on August 23, 2017 and automatically became effective upon filing. The securities may be offered only by means of a written prospectus, including a prospectus supplement, forming a part of the effective registration statement. A preliminary prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC and will be available on the SEC’s website at www.sec.gov. When available, copies of the preliminary prospectus supplement and the accompanying prospectus may also be obtained by contacting Cantor Fitzgerald & Co., Attention: Capital Markets, 499 Park Ave., 6th Floor, New York, New York 10022, or by email at This email address is being protected from spambots. You need JavaScript enabled to view it..This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities being offered, nor shall there be any sale of the securities being offered in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.About GBT


Posted: 2018-12-06 21:05:00

Get Full News Story On GlobeNewsWire Press Release Service


Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.


Print Friendly and PDF Share Embed


Related News Stories From The Web And More

Related Bing News

Press Release: Global Blood Therapeutics Announces Proposed Public Offering of Common Stock | Globe NewsWire News Distribution Service | RobinsPost News Network - Newscast

NeoGenomics, Inc.: NeoGenomics Announces Proposed Public Offering of Common Stock

Mon, 20 May 2019 13:20:00 GMT

FT. MYERS, FL / ACCESSWIRE / May 20, 2019 / NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it has commenced an underwritten public ...

Guardant Health, Inc. Announces Proposed Public Offering of Common Stock

Mon, 20 May 2019 13:19:00 GMT

REDWOOD CITY, May 20, 2019 (GLOBE NEWSWIRE via COMTEX) -- Guardant Health, Inc. GH, +2.74% a leading precision oncology company focused on helping conquer cancer globally through use of its ...

NeoGenomics Announces Proposed Public Offering of Common Stock

Mon, 20 May 2019 13:11:00 GMT

May 20, 2019 (ACCESSWIRE via COMTEX) -- FT. MYERS, FL / ACCESSWIRE / May 20, 2019 / NeoGenomics, Inc. NEO, +0.87% a leading provider of cancer-focused genetic testing services, announced today that it ...

Insmed Announces Proposed Public Offering of Common Stock

Mon, 20 May 2019 13:10:00 GMT

BRIDGEWATER, N.J., May 20, 2019 /PRNewswire/ -- Insmed Incorporated (INSM) announced today that it has commenced an underwritten public offering of up to $250 million of its common stock. ...

Superconductor Technologies Inc. Announces Proposed Public Offering of Common Stock

Mon, 20 May 2019 02:50:00 GMT

AUSTIN, Texas, May 20, 2019 (GLOBE NEWSWIRE) -- Superconductor Technologies Inc. ("STI," the "Company," "we," "our" or "us") (NASDAQ:SCON) today announced that it intends to offer and sell, subject to ...

Related Bing Web Search

PhaseBio Announces Proposed Public Offering of Common Stock

(Tue, 09 Apr 2019 21:20:00 GMT)

PhaseBio Pharmaceuticals, Inc. (PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for orphan diseases, today announced that it ...

Zosano Pharma Announces Proposed Public Offering of Common ...

(Sun, 07 Apr 2019 23:59:00 GMT)

Zosano Pharma Corporation (ZSAN), a clinical-stage biopharmaceutical company, today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares ...

Initial public offering - Wikipedia

(Sat, 18 May 2019 21:45:00 GMT)

Initial public offering (IPO) or stock market launch is a type of public offering in which shares of a company are sold to institutional investors and usually also retail (individual) investors; an IPO is underwritten by one or more investment banks, who also arrange for the shares to be listed on one or more stock exchanges.Through this process, colloquially known as floating, or going public ...

Parsons Corporation Files Registration Statement for ...

(Sat, 18 May 2019 21:45:00 GMT)

CENTREVILLE, VA (April 12, 2019) – Parsons Corporation (“Parsons”), a provider of technology-driven solutions in the defense, intelligence and critical infrastructure markets, today announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) relating to the proposed initial public offering of its common stock.

HYLETE, Inc. Files Registration Statement For Proposed ...

(Thu, 18 Apr 2019 11:51:00 GMT)

SOLANA BEACH, Calif., April 18, 2019 /PRNewswire/ -- HYLETE, Inc. today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange ...

www.sec.gov

(Thu, 16 May 2019 14:45:00 GMT)

If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box.

Form S-1 - SEC.gov

(Fri, 17 May 2019 13:11:00 GMT)

Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective.. If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act, check the following box: ¨

NVCN Stock Price - Neovasc Inc. Stock Quote (U.S.: Nasdaq ...

(Sat, 18 May 2019 18:32:00 GMT)

Neovasc Inc. stock price, stock quotes and financial overviews from MarketWatch.

Veracyte

(Sat, 18 May 2019 04:41:00 GMT)

Veracyte's genomic tests have the potential to save billions of dollars each year in unnecessary surgery costs.

NSPR Stock Price - InspireMD Inc. Stock ... - MarketWatch

(Sat, 18 May 2019 18:24:00 GMT)

InspireMD Inc. InspireMD, Inc. is a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and ...

Related News Story Videos From Youtube

Common Stock Offerings Explained – Lesson On How It Relates To PENNY STOCKS – Tesla $250M Offering


Related Videos On: Common Stock Offerings Explained – Lesson On How It Relates To PENNY STOCKS – Tesla $250M Offering


Public offerings secondary offerings shelf offerings stock market


Related Videos On: Public offerings secondary offerings shelf offerings stock market


Public Offering Of Common Stock


Related Videos On: Public Offering Of Common Stock


How an Initial Public Offering (IPO) Works


Related Videos On: How an Initial Public Offering (IPO) Works


Initial public offerings, or IPOs, explained


Related Videos On: Initial public offerings, or IPOs, explained






Blow Us A Whistle

Comments (Whistles) Designed By Disqus




Company Information

Official Content Providers











PRIVACY POLICY

We recommend Firefox 3 (and above), Edge, and Chrome for dynamic performance.
© 2008-2019 RobinsPost (The Bird's Eye View Company) All rights are reserved.
RobinsPost provides links to news sites based on their RSS feeds.
All trademarks, copyrights, videos, photos and logos are owned by news sources.
News stories, videos and live streams are from trusted sources:
Bing News, Google News, NewsApi.org and YouTube Search Results.
ROBINSPOST Is Proudly Made In America.
Where Quality, Safety and Service Comes First.